MktsMarkets

Barinthus Biotherapeutics plc
NASDAQ: BRNSKey statistics
BRNS News
Stories mentioning BRNS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 14,969 | 0.00 | ||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | |||||
| Operating Expenses | ||||||||
| Research & Development | 3,593 | 3,931 | 5,390 | 7,953 | 8,290 | 8,310 | 11,139 | 11,662 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 6,121 | 11,573 | 15,222 | 23,337 | 20,929 | 23,574 | 24,559 | 18,863 |
| Operating Income (Loss) | (6,075) | (11,565) | (15,066) | (23,324) | (20,600) | (23,390) | (9,380) | (18,286) |
| Interest Income | 350.00 | 406.00 | 472.00 | 523.00 | 556.00 | 637.00 | 631.00 | 635.00 |
| Interest Expense | ||||||||
| Other Expense | 39.00 | (104.00) | (275.00) | 320.00 | 75.00 | 89.00 | 26.00 | 20.00 |
| Pretax Income | (5,550) | (11,160) | (14,642) | (21,151) | (19,680) | (20,588) | (8,132) | (16,950) |
| Tax Provision | (16.00) | (57.00) | (71.00) | (25.00) | (22.00) | 3.00 | (3.00) | (7.00) |
| Net Income (Loss) | (5,531) | (11,090) | (14,566) | (21,124) | (19,648) | (20,540) | (8,114) | (16,931) |
| Earnings Per Share (Basic) | (0.14) | (0.27) | (0.36) | (0.52) | (0.49) | (0.52) | (0.21) | (0.43) |
| Earnings Per Share (Diluted) | (0.14) | (0.27) | (0.36) | (0.52) | (0.49) | (0.52) | (0.21) | (0.43) |
| Weighted Average Shares Outstanding (Basic) | 40,849 | 40,527 | 40,661 | 40,344 | 40,265 | 39,348 | 39,419 | 39,041 |
| Weighted Average Shares Outstanding (Diluted) | 40,849 | 40,527 | 40,661 | 40,344 | 40,265 | 39,348 | 39,419 | 39,041 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BRNS
Barinthus Biotherapeutics plc (NASDAQ: BRNS) is a stock listed on the Nasdaq Stock Market under the ticker symbol BRNS. It last traded at $0.0000 (Dec 31, 1969, 7:00 PM ET), down 2.5% on the day. That gives Barinthus Biotherapeutics a market capitalisation of $30.2M.
Over the past 52 weeks BRNS has traded between $0.5100 and $1.40.
For the quarter ended Mar 31, 2026 it reported a net loss of $5.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$5.5M |
| Dec 31, 2025 | — | -$11.1M |
| Sep 30, 2025 | $0 | -$14.6M |
| Jun 30, 2025 | — | -$21.1M |
From Barinthus Biotherapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…